“This emerging evidence can support prescribers’ level of confidence in off-label prescribing of psychostimulants to patients with stimulant use disorder (and particularly for patients with
and stimulant use disorder),” write Drs. Heather Palis, University of British Columbia, and Scott MacDonald, Providence Health Care, Vancouver, BC.
In 2020, Canada’s Federal Minister of Health issued a letter to the provinces and territories to encourage increasing access to safer pharmaceutical-grade drugs as an alternative to contaminated illegal drugs. Only BC has issued guidance on prescribing psychostimulants to people at risk of overdose (1✔ ✔Trusted Source
Incorporating prescription psychostimulants into the continuum of care for people with stimulant use disorder in Canada
Go to source
Prescribed Psychostimulants as a Key Component in Overcoming Illicit Stimulant Dependency
To help implement prescribed psychostimulants in Canada, the authors suggest that clinical practice guidance should be updated based on new evidence, and that substance use treatment programs and clinics establish protocols to incorporate psychostimulants into the range of interventions.
“Broader implementation of prescribed psychostimulants as an effective option in the continuum of care for stimulant use disorder is needed in Canada; this practice would help the growing number of patients seeking to reduce their reliance on the illegal stimulant supply during the ongoing unregulated drug poisoning crisis,” they conclude.
- Incorporating prescription psychostimulants into the continuum of care for people with stimulant use disorder in Canada – (https://www.cmaj.ca/content/195/27/E934)